Gene therapy genetic aspects and possibilities for degenerative diseases of intervertebral disks treatment
DOI:
https://doi.org/10.25305/unj.108520Keywords:
degenerative diseases of intervertebral disks, minimally invasive surgery, biotechnology, growth factors, gene therapy.Abstract
At the beginning of 90th past century, due to intensive development of molecular biology and tissue engineering, knowledge accumulation about growth factors influence on the intervertebral disc cells, became possible. For the last few years, there were made a lot of experimental works dedicated to the growth factors, and their combination with gene therapy for intervertebral disc biological regeneration. The study of gene therapy possibilities becomes more interesting and perspective, as potentially becomes possible not only to stop the progress of intervertebral disc degeneration, but also to its regeneration. We showed basic principles and pre-conditions for this method study, and also described the main experimental and clinical research studies. Positive results of the investigations enabled to forecast the changes in spine degenerative diseases surgery in the future, making it less invasive and more effective.References
Adam S., Chadderdon R., Gilberts L. et al. Gene therapy approaches for intervertebral disc degeneration // Spine. — 2004. — V.29. — P.2770–2778.
Alden T.D., Pittman D.D, Beres E.J. et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy // J. Neurosurg. — 1999. — V.90. — P.109–114.
An H., Thonar E., Masuda K. Biological repair of intervertebral disc // Spine. — 2003. — V.28. — P.86–92.
Battie M.C., Videman T. Lumbar disc degeneration: epidemiology and genetics // J. Bone Jt. Surg. — 2006. — V.88. — P.3–9.
Battie M.C., Videman T., Gibbons L.E. Determinants of lumbar disc degeneration. A study relating lifetime exposures and magnetic resonance imaging findings in identical twins: 995 Volvo Award in clinical sciences // Spine. — 1995. — V.20. — P.2601–2612.
Beneke R. Zur lehre von der spondylitis deformans // Versammlung deutscher Naturforscher und arzte. — 1897. — H.4. — S.69.
Boden S.D., Liu Y., Hair G. et al. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation // Endocrinology. — 1998. — V.139. — P.5125–5134.
Boden S.D., Titus L., Hair G. et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1) // Spine. — 1998. — V.23. — P.2486–2492.
Boos N., Weissbachs S., Rohrbach H. Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo award // Spine. — 2002. — V.27. — P.2631–2644.
Cha Ch., Boden S. Gene therapy applications for spine fusion // Spine. — 2003. — V.28. — P.74–84.
Chan D., Song Y., Sham P. et al. Genetics of disc degeneration // Eur. Spine J. — 2006. — V.15, suppl.3. — P.317–325.
Cheung K.M., Chan D., Karppinen J. Association of the TaqI allele in vitamin D receptor with degenerative disc disease and disc bulge in Chinese // Spine. — 2006. — V.31. — P.1141–1148.
Corey J., Gilbertson L., Kang J. Gene therapy applications for intervertebral disc degeneration // Spine. — 2003. — V.28. — P.93–98.
Evans Ch. Potential biologic therapies for the intervertebral disc // J. Bone Jt. Surg. — 2006. — V.88. — P.95–98.
Friedmann T., Roblin R. Gene therapy for human genetic disease? // Science. — 1972. — V.175. — P.949–955.
Grant S.F., Reid D.M., Blake G. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene // Nat. Genet. — 1996. — V.14. — P.203–205.
Helm G.A., Aiden T.D., Beres E.J. et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent // J. Neurosurg. — 2000. — V.92. — P.191–196.
Jim J.J., Noponen-Hietala N., Cheung K.M. The TRP2 allele of COL9A2 is an age dependent risk factor for the development and severity of intervertebral disc degeneration // Spine. — 2005. — V.30. — P.2735–2742.
Kang J.D., Georgescu H.I., Intyre-Larkin L. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukine-6, and prostaglandin E2 // Spine. — 1996. — V.21. — P.271–277.
Matsumoto T., Masuda K., Chen S. et al. Transfer of osteogenic protein-1 gene by gene gun system promotes matrix synthesis in bovine intervertebral disc and articular cartilage cells // Orthop. Res. Soc. — 2001. — V.30. — P.849–876.
Moon S.H., Gilbertson L.G., Nishida K. et al. Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer // Spine. — 2000. — V.25. — P.2573–2579.
Moon S.H., Nishida K., Gilbertson L.G. et al. Biologic response of human intervertebral disc cell to gene therapy cocktail // Orthop. Res. Soc. — 2001. — V.30. — P.883–886.
Moon S.H., Nishida K., Gilbertson L.G. et al. Responsiveness of human intervertebral disc cells to adenovirus mediated transfer of TGF-1 cDNA in 2D and 3D culture systems: Comparison to exogenous TGF-1 // Abstr. Intern. Society for the Study of the Lumbar Spine. — Adelaide (Australia), 2002. — P.145–146.
Neidlinger-Wilke C., Wurtz K., Urban J. et al. Regulation of gene expression in intervertebral disc cells by low and high hydrostatic pressure // Eur. Spine J. — 2006. — V.15, suppl.3. — P.372–378.
Nishida K., Kang J.D., Gilbertson L.G. et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene // Spine. — 1999. — V.24. — P.2419–2425.
Nishida K., Kang J.D., Suh J.K. et al. Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration // Spine. — 1999. — V.23. — P.2437–2442.
Nishida K., Gilbertson L.G., Robbins P. D. et al. Potential applications of gene therapy to the treatment of intervertebral disc disorders // Clin. Orthop. Relat. Res. — 2000. — N.379. — P.234–241.
Paul R., Haydon R., Ishikawa A. Potential use of Sox9 gene therapy for intervertebral degenerative disc desease // Spine. — 2003. — V.28. — P.755–763.
Riew D., Lou J., Wright N. et al. Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique // J. Bone Jt. Surg. — 2003. — V.85. — P.866–871.
Roughley P.J. Parameters that influence change in nucleus pulposus composition // Spine. — 2004. — V.29. — P.2691–2699.
Sandhu H., Boden S., Kang J. et al. BMP’s and gene therapy for spinal fusion (summary statement) // Spine. — 2003. — V.28. — P.85.
Seguin C.A., Pilliar R.M., Roughley P.J. et al. Tumor necrosis factor (alpha) modulates matrix production and catabolism in nucleus pulposus tissue // Spine. — 2005. — V.30. — P.1940–1948.
Solovieva S., Lohiniva J., Leino-Arjas P. COL9A3 gene polymorphism and obesity in intervertebral disc degeneration of the lumbar spine: evidence of gene-environment interaction // Spine. — 2002. — V.27. — P.2691–2696.
Steinmann J.C., Herkowitz H.N. Pseudarthrosis of the spine // Clin. Orthop. — 1992. — V.284.— P.80–90.
Uitterlinden A.G., Fang Y., van Meurs J.B. Genetics and biology of vitamin D receptor polymorphisms // Gene. — 2004. — V.338. — P.143–156.
Wallach C.J., Sobajima S., Watanabe Y. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglicans in human intervertebral disc cells // Abstr. Intern. Society for the Study of the Lumbar Spine. — Cleveland, Ohio, 2002. — P.67.
Wehling P., Schulitz K.P., Robbins P.D. et al. Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy // Spine. — 1997. — V.22. — P.1092–1097.
Yoo J.U., Mandell I., Angele P. et al. Chondrogenitor cells and gene therapy // Clin. Othop. Relat. Res. — 2000. — N379. — P.164–170.
Yoon T.S., Patel N. Molecular therapy of the intervertebral disc // Eur. Spine J. — 2006. — V.15, suppl.3. — P.379–388.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2008 E. G. Pedachenko, K. I. Horbatyuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
